11 employees
AngioChem develops new drugs that are capable of crossing the blood-brain barrier to treat brain diseases.
2003
$4M
from 2 investors over 2 rounds
Angiochem raised $4M on June 4, 2019
Investors: Gouvernement du Québec – Carrières
Angiochem raised $3M on December 1, 2007
Investors: MMV Financial